ENTITY
Raqualia Pharma

Raqualia Pharma (4579 JP)

6
Analysis
Health Care • Japan
RaQualia Pharma, Inc. is a pharmaceutical company. The Company develops compounds for patient studies and sells drugs to pharmaceutical manufacturers. RaQualia also provides research on remedies in gastrointestinal, liver diseases, and pain in general areas.
more
bullish•Raqualia Pharma
•17 Aug 2026 10:00•Issuer-paid

Raqualia Pharma (4579 JP): 1H FY12/26 flash update

Operating revenue decreased 5.2% YoY, with a JPY339mn operating loss, reflecting absence of upfront and milestone payments. Royalties increased...

Logo
89 Views
Share
bullish•Raqualia Pharma
•15 Aug 2025 10:01•Issuer-paid

Raqualia Pharma (4579 JP): 1H FY12/25 flash update

Operating revenue increased to JPY1.5bn (+8.9% YoY), with a net loss of JPY355mn and R&D expenses at JPY782mn. Royalty income from four...

Logo
264 Views
Share
bullish•Raqualia Pharma
•16 May 2025 13:00•Issuer-paid

Raqualia Pharma (4579 JP): Q1 FY12/25 flash update

Operating revenue increased by 48.8% YoY to JPY965mn, with operating profit rising 109.2% YoY to JPY93mn. Royalty income from four products and...

Logo
363 Views
Share
bullish•Raqualia Pharma
•15 Nov 2024 09:00•Issuer-paid

Raqualia Pharma (4579 JP): Q3 FY12/24 flash update

Operating revenue increased to JPY2.4bn (+58.4% YoY), with a net loss of JPY340mn, driven by rising R&D expenses. Royalty income from four...

Logo
233 Views
Share
bullish•Raqualia Pharma
•15 Aug 2024 11:00•Issuer-paid

Raqualia Pharma (4579 JP): 1H FY12/24 flash update

Operating revenue increased to JPY1.4bn (+39.1% YoY), with an operating loss of JPY154mn and a recurring loss of JPY278mn. Royalty income from...

Logo
288 Views
Share
x